NCT04229888已完成不适用
Meibomian Gland Dysfunction Treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 14
- 试验地点
- 2
- 主要终点
- Dry Eye Questionnaire 5 (DEQ-5) Score
研究概览
简要总结
The purpose of this study is to evaluate the effectiveness of treatments for Meibomian Gland Dysfunction.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
盲法说明
Outcomes assessor blinded to visit schedule. Participants masked to invalidity of sham treatment.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •evidence of meibomian gland obstruction in both eyes
- •dry eye symptoms per DEQ-5
排除标准
- •active ocular infection
- •previous LipiFlow treatment
- •beginning new oral or other systemic medications within prior 3 months
- •beginning new or changing dosages of ocular medications within prior 3 months
- •previous ocular surgery, trauma, herpes, recurrent inflammation, punctal plugs in prior 3 months
- •habitual contact lens wear in prior 3 months
- •women who are pregnant or nursing
结局指标
主要结局
Dry Eye Questionnaire 5 (DEQ-5) Score
时间窗: 2 weeks
DEQ5 total score ranges from 0-22 with the higher scores indicating increased dry eye.
次要结局
- Tear Break-Up Time (TBUT)(2 weeks)
- Meibomian Gland Score(2 weeks)
研究者
Anna Tichenor
Assistant Scientist
Indiana University
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Treatment of Meibomian Gland Dysfunction Prior to Cataract SurgeryBlepharitisDry Eye SyndromeNCT01808560TearScience, Inc.34
已完成
不适用
iLux Treatment for Meibomian Gland Dysfunction (MGD)Evaporative Dry EyeNCT03055650Tear Film Innovations, Inc.30
已完成
不适用
Survey of Meibomian gland dysfunctioMeibomian gland dysfunctionJPRN-UMIN000018508Inouye Eye Hospital500
已完成
4 期
Intraductal Meibomian Gland Probing TrialMeibomian Gland DysfunctionNCT02256969Joseph B. Ciolino, MD45
已完成
不适用
Clinical Evaluation of Therapeutic Meibomian Gland ExpressionVisual AcuityMeibomian GlandNCT04997135Johnson & Johnson Vision Care, Inc.16